ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
21 announcements with these filters
Borosil Scientific Limited held its 35th Annual General Meeting on September 25, 2026, via video conferencing to transact business stated in the notice.
Mr. Kailash Motwani, Head of Operations at material subsidiary Pune & Goel Scientific Glass Works Limited, has resigned from his position as Senior Management Personnel.
Borosil Scientific's board approved ₹60 Crore to build a new glassware plant in Bharuch. Capacity will expand from ~15 to ~108 lakhs units annually by March 2027.
Borosil Scientific Limited has communicated the web link for the Annual Report and AGM Notice to shareholders whose email addresses were not registered. The AGM is scheduled for September 25, 2026.
Borosil Scientific Limited has released its Annual Report for FY 2025-26. The 35th Annual General Meeting is scheduled for September 25, 2026, via video conferencing.
Borosil Scientific Limited will hold its 35th Annual General Meeting on September 25, 2026, via video conferencing. Remote e-voting is scheduled from September 22 to September 24.
Borosil Scientific Limited allotted 4,475 equity shares under its Employee Stock Option Scheme. The new shares rank pari-passu with existing equity shares.
Borosil Scientific reported Q1FY27 consolidated net sales of Rs. 106.8 Cr (11.2% YoY growth). Strategy focuses on diversifying from lab glassware into high-margin process equipment and pharma packaging.
Borosil Scientific Ltd reported revenue from operations of ₹106.8 Cr (+11.2% YoY) and net profit of ₹4.4 Cr for Q1 FY27.
Borosil Scientific Ltd has scheduled a board meeting on August 3, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Sharad Tiwari ceased being Senior Managerial Personnel effective July 14, 2026. He remains associated with the company despite internal reporting structure changes.
Borosil Scientific clarified that the recent surge in its share volume is market driven. No material information was withheld.
Borosil Scientific delivered strong Q4FY26 results with Consolidated Net Sales up 10.6% and EBITDA up 87.6% YoY, driven by operational efficiency and scientific segment growth.
Borosil Scientific Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with SEBI guidelines.
Borosil Scientific Limited granted 18,700 stock options at Rs. 108 per option. This employee incentive scheme represents a potential equity dilution of 18,700 shares.
Borosil Scientific Limited board approved seeking shareholder approval for fund raising through multiple modes. Precise terms and amounts will be determined at a later date.
Borosil Scientific appointed Ramavtar Sharma as Company Secretary following Sanjay Gupta's resignation. The firm also re-appointed Vinayak Patankar as CEO for a three-year term.
Borosil Scientific Ltd reported revenue from operations of ₹143.2 Cr (+10.6% YoY) and net profit of ₹27.2 Cr (+216.3% YoY) for Q4 FY26.
Borosil Scientific Limited reported its FY26 results and approved a ₹250 Crore fundraise. The board also re-appointed Vinayak Patankar as CEO for three years.
Borosil Scientific scheduled a board meeting on May 20, 2026, to approve audited financials and consider raising funds. Investors should monitor outcomes regarding capital expansion plans.
Borosil Scientific Limited submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The registrar confirmed that all securities are in dematerialized form and no Demat/Remat requests were received during the period. This is a standard regulatory disclosure.